Rxi Pharmaceuticals Offers Great Risk-Reward Scenario Before Major Catalysts By: TalkMarkets November 14, 2014 at 11:05 AM EST Rxi Pharmaceuticals is extremely undervalued should approaching catalysts fulfill promise. Read More >> Related Stocks: Regulus Therapeutics